Medtronic
This article was originally published in The Gray Sheet
Executive Summary
International release of the 55 cc, 93 gram Jewel AF implantable arrhythmia management device begins July 27. Designed especially for patients whose disease state may change after device implantation, Jewel AF is capable of treating ventricle arrhythmia, atrial fibrillation and slow heartbeats in both chambers, the company says